|
市場調査レポート
商品コード
1384812
ヘルニアメッシュデバイスの世界市場規模、シェア、産業動向分析レポート:タイプ別、ヘルニアタイプ別、地域別展望と予測、2023年~2030年Global Hernia Mesh Devices Market Size, Share & Industry Trends Analysis Report By Type (Synthetic and Biologic), By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others), By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
ヘルニアメッシュデバイスの世界市場規模、シェア、産業動向分析レポート:タイプ別、ヘルニアタイプ別、地域別展望と予測、2023年~2030年 |
出版日: 2023年10月31日
発行: KBV Research
ページ情報: 英文 260 Pages
納期: 即納可能
![]() |
ヘルニアメッシュデバイス市場規模は、予測期間中にCAGR 6.9%で成長し、2030年には82億米ドルに達すると予測されます。2022年の市場規模は2,004万7,100個で、成長率は6.6%(2019-2022年)です。
しかし、患者の中には、感染症、慢性疼痛、メッシュの移動など、ヘルニアメッシュデバイスに関連する合併症を経験する人もいます。これらの合併症は再手術につながる可能性があり、患者の満足度に影響を与え、ヘルスケアコストを増加させる。感染症、慢性疼痛、メッシュの移動など、ヘルニアメッシュ手術による合併症は、これらの器具に対する患者の信頼と信用を損ないかねません。合併症を経験した患者は、さらなるヘルニア修復手術を受けることをためらい、市場の成長に影響を与えます。ヘルニアメッシュ器具による合併症は、メーカーに対する訴訟や法的措置につながっています。加えて、メーカーは規制上の課題にも直面しています。そのため、手術の難しさや再手術の必要性が市場の課題となっています。
パンデミックは、ヘルニアメッシュ製品などの医療機器のサプライチェーンの混乱を引き起こしました。ロックダウン、旅行制限、個人用保護具(PPE)の需要増は、ヘルニアメッシュ機器の生産と流通に影響を与えました。その結果、製造や配送に遅れが生じ、ヘルスケア施設のヘルニア手術の実施能力に影響を与えました。世界中の多くのヘルスケアシステムと政府は、COVID-19患者のためのリソースを優先するために、選択的手術を延期またはキャンセルしました。ヘルニア修復手術、特に緊急でないと考えられる手術は延期されました。このため、手術件数が減少し、ヘルニア用メッシュ器具の需要に大きな影響を与えました。
ヘルニアタイプの展望
ヘルニアの種類によって、市場は鼠径ヘルニア、切開ヘルニア、大腿ヘルニア、その他に分類されます。2022年には、鼠径ヘルニア分野が市場で最も高い収益シェアを占めました。鼠径ヘルニアの有病率の上昇は、人口の高齢化とライフスタイルに関連した危険因子の影響を受けており、ヘルニアメッシュデバイスの需要を煽っています。鼠径ヘルニアがより一般的になるにつれ、ヘルスケアプロバイダーは治療プロトコルでヘルニアメッシュデバイスを利用する傾向が強くなっています。ヘルニアメッシュ器具は鼠径ヘルニア修復におけるヘルニア再発のリスクを効果的に低減します。メッシュを使用することで、より良い治療成績と患者満足度が得られるため、外科医やヘルスケア施設はこれらの器具を採用するようになっています。
タイプ別展望
タイプ別に見ると、市場は生物学的製剤と合成樹脂製剤に二分されます。2022年には、生物学的メッシュ分野が市場で大きな収益シェアを占めています。生物学的メッシュは自然組織の修復とリモデリングプロセスを促進します。時間が経つにつれて、これらのメッシュは徐々に患者の体内に吸収され、患者の組織と入れ替わる。この機能は、長期的な構造的支持を必要とするが、合成メッシュに関連した合併症のリスクがある患者にとって特に有益です。生物学的メッシュの安全性プロファイルは、感染症、汚染創、メッシュ関連合併症の既往歴のある患者など、特定の患者集団に対して優れています。生物学的メッシュは感染、びらん、癒着形成などの合併症を起こしにくいです。
地域別展望
地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が最も高い収益シェアを獲得して市場をリードしました。北米の市場には、合成メッシュ、生物学的メッシュ、複合メッシュを含む幅広いヘルニアメッシュデバイスが含まれます。座りがちなライフスタイル、高齢者人口の増加、ヘルニア再発リスクの高さが北米市場の拡大を後押ししています。
The Global Hernia Mesh Devices Market size is expected to reach $8.2 billion by 2030, rising at a market growth of 6.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 20,047.1 thousand units, experiencing a growth of 6.6% (2019-2022).
The market in Asia Pacific region is being driven by factors like expanding medical tourism, inexpensive treatment options, technological development, and increasing healthcare reimbursements. Thus, the APAC region generated $1,009.7 million revenue in the market in 2022. Furthermore, the demand for hernia repair devices is rising in Asia, particularly Japan and China, due to the region's large patient population. Many undiagnosed and untreated cases are anticipated to fuel the market expansion in this region, which is expected to experience robust growth. Some of the factors impacting the market are increasing prevalence of hernias, improved fixation techniques, and complications leading to revision surgeries.
The growing prevalence of hernias, including inguinal, incisional, ventral, umbilical, and femoral hernias, is a primary driver of the market. Factors such as an aging population, obesity rates, and lifestyle choices contribute to the rise in hernia cases. As per a report by the National Library of Medicine updated in 2023, there were 32.53 million prevalent cases and 13.02 million incident cases of inguinal, femoral, and abdominal hernias globally in 2019, representing increases of 36.00% and 63.67 %, respectively. Medical conditions like chronic obstructive pulmonary disease, constipation, and other factors that cause chronic coughing or straining can lead to an increased risk of hernias. Additionally, Innovations in mesh fixation techniques, including self-gripping meshes, have simplified the surgical process, and reduced the need for additional fixation devices, making hernia repair procedures more efficient. Improved fixation methods lead to shorter operating times. This is particularly valuable for surgeons and healthcare facilities as it allows for more efficient resource utilization and increased surgeries performed in each time frame. Many advanced fixation techniques are well-suited for minimally invasive surgical procedures, such as laparoscopy and robotic-assisted surgery. The growing adoption of fixation techniques improves the overall quality of hernia repair surgeries. This, in turn, contributes to the sustained growth of the market.
However, some patients experience complications related to hernia mesh devices, such as infections, chronic pain, or mesh migration. These complications can lead to revision surgeries, impacting patient satisfaction and increasing healthcare costs. Complications from hernia mesh procedures, such as infections, chronic pain, or mesh migration, can erode patient confidence and trust in these devices. Patients who experience complications hesitate to undergo further hernia repair surgeries, affecting the market's growth. Complications from hernia mesh devices have led to lawsuits and legal actions against manufacturers. In addition, manufacturers face increased regulatory challenges. Thus, difficulties and the need for revision surgeries challenge the market.
The pandemic caused supply chain disruptions for medical devices, such as hernia mesh products. Lockdowns, travel restrictions, and increased demand for personal protective equipment (PPE) affected the production and distribution of hernia mesh devices. This resulted in manufacturing and delivery delays, affecting healthcare facilities' ability to perform hernia surgeries. Many healthcare systems and governments around the world postponed or canceled elective surgeries to prioritize resources for COVID-19 patients. Hernia repair surgeries, especially those considered non-urgent, were deferred. This significantly impacted the demand for hernia mesh devices, as fewer surgeries were being performed.
Hernia Type Outlook
By hernia type, the market is categorized into inguinal hernia, incisional hernia, femoral hernia, and others. In 2022, the inguinal hernia segment held the highest revenue share in the market. The rising prevalence of inguinal hernias, influenced by aging populations and lifestyle-related risk factors, fuels the demand for hernia mesh devices. As inguinal hernias become more common, healthcare providers are more likely to utilize hernia mesh devices in their treatment protocols. Hernia mesh devices effectively reduce the risk of hernia recurrence in inguinal hernia repair. Using mesh offers better outcomes and patient satisfaction, encouraging surgeons and healthcare facilities to adopt these devices.
Type Outlook
Based on type, the market is bifurcated into biologic and synthetic. In 2022, the biologic mesh segment witnessed a substantial revenue share in the market. Biologic meshes promote the natural tissue repair and remodeling process. Over time, these meshes are gradually absorbed by the patient's body and replaced with their tissue. This feature is especially beneficial for patients who require long-term structural support but may be at risk of synthetic mesh-related complications. The safety profile of biologic meshes is superior for specific patient populations, such as those with infections, contaminated wounds, or a history of mesh-related complications. Biologic meshes are less prone to complications like infection, erosion, or adhesion formation.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The market in North America includes a wide range of hernia mesh devices, including synthetic meshes, biologic meshes, and composite meshes. Sedentary lifestyles, a growing elderly population, and a high risk of hernia recurrence drive North America's market expansion.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson and Company, Johnson & Johnson, W. L. Gore & Associates, Inc., Atrium Medical Corporation (Getinge AB), B. Braun Melsungen AG, Baxter International, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Integra LifeSciences Holdings Corporation, and Herniamesh S.r.l.
Market Segments covered in the Report:
By Type (Volume, thousand units, USD Million, 2019-2030)
By Hernia Type (Volume, thousand units, USD Million, 2019-2030)
By Geography (Volume, thousand units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research